Novo Nordisk A/S: Wegovy Pill Approved in the U.S
Hydration and Monitoring Maintaining adequate hydration is essential when using both medications: Wegovy can cause nausea, vomiting, or diarrhoea, potentially leading to dehydration Dehydration can increase the risk of NSAID-related kidney problems Ensure regular fluid intake, particularly during Wegovy dose escalation phases For long-term NSAID therapy, the Specialist Pharmacy Service recommends baseline and periodic monitoring of renal function, blood pressure, and full blood count
Seek Medical Advice: Consult a healthcare provider promptly if nausea is severe, persistent, or accompanied by vomiting
Results vary based on individual factors and adherence to lifestyle modifications
Semaglutide for weight loss is found under the brand name Wegovy, which is available in the form of an injectable weight loss pen, and a tablet